A randomized controlled trial of a brief behavioral intervention to reduce skin and soft tissue infections among people who inject drugs

被引:11
|
作者
Phillips, Kristina T. [1 ]
Stewart, Catherine [2 ]
Anderson, Bradley J. [3 ]
Liebschutz, Jane M. [4 ]
Herman, Debra S. [3 ,5 ]
Stein, Michael D. [2 ]
机构
[1] Kaiser Permanente Hawaii, Ctr Integrated Hlth Care Res, Honolulu, HI 96817 USA
[2] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA
[3] Butler Hosp, Behav Med & Addict Res, Providence, RI 02906 USA
[4] Univ Pittsburgh, Ctr Res Hlth Care, Div Gen Internal Med, Pittsburgh, PA 15213 USA
[5] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA
基金
美国国家卫生研究院;
关键词
Skin infections; Abscesses; Bacterial infections; People who inject drugs; Injection drug use; Heroin; USERS; ABSCESSES; PREVALENCE; CELLULITIS; BACTERIAL; HEROIN; NEEDLE; SAMPLE; COSTS; HIV;
D O I
10.1016/j.drugalcdep.2021.108646
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: People who inject drugs (PWID) are at high risk for skin and soft tissue infections (SSTIs), but few interventions have targeted their reduction. The goal of the current study was to test the effects of a brief skin and needle hygiene behavioral intervention (SKIN) in a two-group randomized controlled trial with 12-month followup. Method: PWID (N = 252) were recruited from inpatient hospital units at a single urban medical center site and randomly assigned to an assessment-only (AO) condition or SKIN, which was a two-session intervention that included psychoeducation, behavioral skills demonstrations, and motivational interviewing. Mixed effects generalized linear models assessed the impact of the intervention on frequency of: 1) self-reported SSTIs, 2) uncleaned skin injections, and 3) injection. Results: Participants were 58.3 % male, 59.5 % White, and averaged 38 years of age. SKIN participants had 35 % fewer SSTIs compared to AO (p = .179), a difference of nearly one infection per year. The mean rate of uncleaned skin injections was about 66 % lower (IRR = 0.34, 95 % CI 0.20; 0.59, p < .001) among SKIN participants compared to AO. Almost one-third of participants reported no injection over follow-up and the mean rate of injection during follow-up was about 39 % lower (IRR = 0.61; 95 % CI 0.36; 1.02, p = .058) among persons randomized to SKIN than AO. Conclusions: The SKIN intervention reduced uncleaned skin injections but did not reduce SSTIs significantly more than a control condition. Brief interventions can improve high-risk practices among PWID and lead to clinically meaningful outcomes.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Efficacy of a network intervention in reducing HIV incidence among people who inject drugs in Ukraine: preliminary results from a clustered randomized trial
    Booth, Robert
    Davis, Jonathan
    Dvoryak, Sergiy
    Brewster, John
    Strathdee, Steffanie
    Latkin, Carl
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2015, 18
  • [42] Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study
    Wheeler, Alice
    Valerio, Heather
    Cunningham, Evan B.
    Martinello, Marianne
    Barocas, Joshua A.
    Colledge-Frisby, Samantha
    Treloar, Carla
    Amin, Janaki
    Henderson, Charles
    Read, Phillip
    Matthews, Gail V.
    Dunlop, Adrian J.
    Gorton, Carla
    Hayllar, Jeremy
    Alavi, Maryam
    Murray, Carolyn
    Marks, Phillipa
    Silk, David
    Degenhardt, Louisa
    Dore, Gregory J.
    Grebely, Jason
    behalf ETHOS Engage Study Grp
    DRUG AND ALCOHOL DEPENDENCE, 2022, 237
  • [43] Challenges of sexually transmitted infections and sexual health among people who inject drugs
    Dumchev, Kostyantyn
    CURRENT OPINION IN INFECTIOUS DISEASES, 2022, 35 (01) : 55 - 60
  • [44] Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)
    Fadnes, Lars T.
    Aas, Christer Frode
    Vold, Jorn Henrik
    Leiva, Rafael Alexander
    Ohldieck, Christian
    Chalabianloo, Fatemeh
    Skurtveit, Svetlana
    Lygren, Ole Jorgen
    Dalgard, Olav
    Vickerman, Peter
    Midgard, Havard
    Loberg, Else-Marie
    Johansson, Kjell Arne
    PLOS MEDICINE, 2021, 18 (06)
  • [45] Accessible Hepatitis C Care for People Who Inject Drugs A Randomized Clinical Trial
    Eckhardt, Benjamin
    Mateu-Gelabert, Pedro
    Aponte-Melendez, Yesenia
    Fong, Chunki
    Kapadia, Shashi
    Smith, Melinda
    Edlin, Brian R.
    Marks, Kristen M.
    JAMA INTERNAL MEDICINE, 2022, 182 (05) : 494 - 502
  • [46] HIV risk reduction among African-American women who inject drugs: A randomized controlled trial
    Sterk, CE
    Theall, KP
    Elifson, KW
    Kidder, D
    AIDS AND BEHAVIOR, 2003, 7 (01) : 73 - 86
  • [47] HIV Risk Reduction Among African-American Women Who Inject Drugs: A Randomized Controlled Trial
    Claire E. Sterk
    Katherine P. Theall
    Kirk W. Elifson
    Daniel Kidder
    AIDS and Behavior, 2003, 7 : 73 - 86
  • [48] The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial
    Jørn Henrik Vold
    Fatemeh Chalabianloo
    Else-Marie Løberg
    Christer F. Aas
    Aaron G. Lim
    Peter Vickerman
    Kjell Arne Johansson
    Lars Thore Fadnes
    Substance Abuse Treatment, Prevention, and Policy, 18
  • [49] The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial
    Vold, Jorn Henrik
    Chalabianloo, Fatemeh
    Loberg, Else-Marie
    Aas, Christer F. F.
    Lim, Aaron G. G.
    Vickerman, Peter
    Johansson, Kjell Arne
    Fadnes, Lars Thore
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2023, 18 (01)
  • [50] The Flawed Reliance on Randomized Controlled Trials in Studies of HIV Behavioral Prevention Interventions for People Who Inject Drugs and Other Populations
    Friedman, Samuel R.
    Perlman, David C.
    Ompad, Danielle C.
    SUBSTANCE USE & MISUSE, 2015, 50 (8-9) : 1117 - 1124